期刊文献+

索非布韦核苷中间体异构体的合成 被引量:2

Synthesis of the Intermediate Isomer of Sofosbuvir
下载PDF
导出
摘要 以S-甘油醛缩丙酮为原料,经Wittig反应、高锰酸钾氧化、磺酰化、氟化、水解、内酯化得索非布韦关键中间体的异构体(3R,4R,5S)-3-氟-4-羟基-5-(羟基甲基)-3-甲基四氢呋喃-2-酮,优化反应条件:n(磺酰氯)/n(化合物3)=1.6/1.0,温度为-10℃,反应2 h;氟化试剂为TEAF(四乙基氟化铵),温度为100℃,反应3 h,制得5S-核苷的总收率为14.21%,化学纯度97.5%,ee值98.4%,经1HNMR,IR和MS(ESI)表征。 The key intermediates(3R,4R,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-dihydrofuran-2(3H)-one for the impurity isomers of Sofosbuvir was synthesized via Wittig reaction,potassium permanganate oxidation,sulfonylation,fluorination,hydrolysis,lactonization from S-glyceraldehyde acetonide as raw material.Optimized reaction conditions:n(sulfonyl chloride)/n(compound 3)=1.6/1.0,reacting at-10℃for 2 h;the fluorination reagent was tetraethylammonium fluoride and reacting at 100℃for 3 h,the total yield of 5S-nucleoside was 14.21%,the purity and ee value were 97.5%and 98.4%,respectively.The structure was characterized by 1H NMR,IR and MS(ESI).
作者 彭晓含 夏天 陈达 张珍明 李树安 PENG Xiao-han;XIA Tian;CHEN Da;ZHANG Zhen-ming;LI Shu-an(College of Chemical Engineering,Jiangsu Ocean University,Lianyungang 222005,China;College of Pharmacy,Jiangsu Ocean University,Lianyungang 222005,China)
出处 《合成化学》 CAS 北大核心 2020年第9期801-805,共5页 Chinese Journal of Synthetic Chemistry
基金 国家自然科学基金资助项目(21606095) 国家海洋公益性行业科研专项(201305007) 江苏省研究生科研创新计划(KYCX18-2610)。
关键词 索非布韦 S-甘油醛缩丙酮 5S-核苷中间体 合成 异构体 sofosbuvir S-glyceraldehyde acetonide 5S-nucleoside intermediate synthesis isomers
  • 相关文献

参考文献4

二级参考文献36

  • 1窦爱兰,钟化人,郝丽晓.氨苄青霉素钠中有机溶媒残留量的测定与考察[J].药物分析杂志,1996,16(6):382-384. 被引量:8
  • 2CHUN B K,WANG Pei-yuan. Preparation of 2'-fluoro- 2'-alkyl-substituted or other optionally substituted ribo- furanosyl pyrimidines and purines and their derivatives: WO ,2006/031 725 [ P ]. 2006-03-23.
  • 3AXT S D, SARMA K, VITALE J, et al. Preparation of nucleosides ribofuranosyl pyrimidines : WO, 2008/045 419 [ P]. 2008-04-17.
  • 4CARR R,HILDBRAND S,HODGES M L,et al. Process for the preparation of 2-deoxy-2-methyl-D-ribofuranosyl nueleoside compounds: WO, 2013/178 571 [ P]. 2013- 12-05.
  • 5REDDY P G,CHUN B K,ZHANG Hai-ren,et al. Stere- oseleetive synthesis of PSI-352938 : a fl-D-2'-deoxy-2'- a-fluoro-2'-fl-C-methyl-3', 5'-cyclic phosphate nueleo-tide prodrug for the treatment of HCV [ J ]. J. Org. Chem. ,2011,76(10) :3 782-3 790.
  • 6WANG Pei-yuan,CHUN B K,RACHAKONDA S,et al. An efficient and diastereoselective synthesis of PSI- 6130: a clinically efficacious inhibitor of HCV NSSB polymerase[ P]. J. Org. Chem. , 2009,74 ( 17 ) : 6 819- 6 824.
  • 7CLARK J L, MASON J C, HOBBS A J, et al. Synthesis of 2-deoxy-2-fluoro-2-C-methyi-D-ribofuranoses [ J ], J. Carbohydr. Chem. ,2006,2S ( 6 ) :461-470.
  • 8ANTONIN H, IVAN R, HANA D. Synthesis of N-( 2- phosphonylmethoxyethyl ) derivatives of heterocyclic base [ J ]. Coll. Czech. Chem. Commun. , 1989, $4 ( $ ) : 2 190-2 210.
  • 9US FDA. FDA approval of sovaldi (sofosbuvir) tablets for the treatment of chronic hepatitis [ EB/OL ]. http:// www. fda. gov/forconsumers/byaudience/forpatientadvo- cates/ucm377920, htm. 2013-12-06.
  • 10EMEA. Sovaldi: EPAR-summary for the public [ EB/ OL]. http://www, ema. europa, eu/ema/index, jsp? curl = pages/medicines/human/medicines/002798/human_med_ 001723. jsp&mid = WC0b01 ac058001 d124. 2014-01-16.

共引文献28

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部